Ensuring Interoperability at Scale with a FHIR-first Approach

A leading US company at the forefront of the clinical genomic diagnostic industry, offering cutting-edge services that are reshaping the healthcare landscape. As a global leader, they are committed to advancing personalized medicine through innovative genetic sequencing and diagnostic solutions. With their experience, technology and dedication to science, they are a trusted force in clinical genetic testing and in developing precision medicine solutions.

The promise of personalized medicine, fueled by cutting-edge genetic testing, holds immense potential to revolutionize healthcare. However, for many labs, the journey from pre-screening to patient results and reimbursement remains fraught with inefficiencies, creating a bottleneck that affects both patient care and financial sustainability. Our client, too, faced similar challenges:

• Overcoming Manual Order Inefficiencies: The lab struggled with outdated, error-prone paper-based and faxed order placement methods, leading to significant delays and bottlenecks. These methods not only compromised patient care but also restricted the lab's growth and its ability to efficiently onboard new providers.
• Addressing EHR Integration Roadblocks: Integrating each new provider's unique Electronic Health Record (EHR) system became a distinct challenge due to the lack of standardization. This lack of standardization forced the lab to invest considerable effort and resources into each integration, making deep integration within provider workflows, crucial for effective data exchange and order placement, a persistent challenge.
• Navigating Pre-Authorization Hurdles: In the absence of a standard screening procedure, the lab had to overcome the challenges of crossing pre authorization hurdles. The team often dealt with incomplete or incorrect documentation, leading to denials or delayed approvals.
• Managing Reimbursement Uncertainties: The lab contended with unpredictable reimbursement cycles, a direct result of the aforementioned challenges. Delayed results, denied claims and convoluted billing processes contributed to financial instability. This instability affected the lab's bottom line and hindered its ability to invest in research and development, putting its competitive edge in personalized medicine at risk.

Coditas stepped in with a multi-pronged approach, understanding the nuances of the genetic testing workflow and the needs of all stakeholders. We developed:

1. Deep EHR Integration

   • Requirement: Streamline the ordering process for providers and eliminate paper-based inefficiencies.

   • Solution: Developed an EHR integration module that allows providers to initiate pre-screening and order tests directly within their existing platform, fostering seamless workflow and data exchange.

2. Patient Portal Integration

   • Requirement: Increase patient transparency and engagement in the pre-screening process.

   • Solution: Integrated the patient portal with the workflow, enabling patients to access their pre-screening results instantly, fostering informed decision-making and empowering them to be active participants in their care journey.

3. GenAI-Driven Pre-Screening

   • Requirement: Ensure accurate and complete pre-authorization documentation to minimize denials and delays.

   • Solution: Developed a GenAI-powered pre-screening module that analyzes patient data and automatically generates comprehensive documentation, adhering to strict payer requirements and reducing the risk of human error.

4. Near Real-Time Data Access

   • Requirement: Optimize workflow efficiency and ensure timely access to critical information.

   • Solution: Implemented near real-time data exchange capabilities, facilitating instant order placement and data transmission between providers, labs, and patients, enabling agile decision-making and efficient lab operations.

The impact of Coditas' solutions reverberated throughout the entire ecosystem, delivering quantifiable results that transformed Client’s operations and empowered them to achieve their goals:

• Our Integration module significantly cut down the time required to onboard large practices, reducing it from about 3 months to just 2 weeks across Electronic Health Records (EHRs).
• The reusability of FHIR endpoints ensured hassle-free subsequent integrations once we built the first integration with the EHR.
• Our engaging pre screening module played a pivotal role in decreasing patient dropout rates by 60%.
• The pre-screening of patients and thorough documentation led to an 80% increase in payor approval rate, significantly higher than the industry standards.
• We managed to shorten the overall genetic testing cycle time dramatically, from 6 weeks down to one and half weeks.
• The platform's efficiency and effectiveness were evident, as it contributed to a 60% increase in reimbursements for providers.

As our client continues to scale and expand their reach, Coditas remains a steadfast partner, committed to providing innovative solutions that anticipate and address evolving needs. Together, we are crafting a future where genetic testing is not just accessible but also seamless, empowering, and a driving force for personalized healthcare on a global scale.